| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |